CEACAM5 and carcinoma: In this model, the use of T cell bispecific [TCB) antibodies, targeting carcinoembryonic antigen (CEA) or fibroblast activating protein (FAP), showed that T cells could be selectively activated to localize and kill either carcinoma cells or fibroblasts.